A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers

Name: A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers
Published: 2015
License: Public Domain

Celgene · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

advanced antibody cc monoclonal

hematologic neoplasms, cc-90002, monoclonal, antibody, cd47, advanced, solid cancers, hematologic cancers, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers

Related documents